Prevalence of COVID-19 in Children in Baden-Württemberg

• Conditions: COVID-19; U07.1; COVID-19, virus identified

• Registration Number: DRKS00021521
• Lead Sponsor: Zentrum für Infektionskrankheiten

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-04-22
• Study Completion: 2021-05-28
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 4964

Inclusion Criteria

Part A:
- Children (male or female) aged 1 to 10 years
- One parent (male or female) without age limit
- Child and parent living in the same household
- Resident in Baden-Württemberg
- Written consent to the study has been obtained

Part B (Amendment 08.05.2020):
If possible, all members of a household in which at least one child or adolescent aged 0-17 years should be included in this study. They must meet the following inclusion criteria:
- Household community consisting of at least one adult and at least one child <18 years and with at least one member with SARS-CoV-2 infection detected by rt-PCR or antibody test, with or without COVID-19 disease
- Children and adolescents (male, female or various) aged 0 to 17 years (up to one day before their 18th birthday) living in the same household
- Adults ( no age limit, male, female or various) living in the same household as the children and adolescents
- Participants are no longer in quarantine due to SARS-CoV-2 infection
- Resident in Baden-Württemberg
- Written consent to the study has been obtained

Part C (Amendment May 18, 2021):
As much as possible, all subjects examined from study part B should be included in part C.
• Participants in part B from a household consisting of at least 1 adult and at least one child <18 years (at the time of participation in part B) and with at least one member with a SARS-CoV-2 infection with or, which has been proven by RT-PCR without COVID-19 disease
• Participants are not in quarantine due to renewed SARS-CoV-2 infection or suspected infection
• Written consent to the study has been obtained

Exclusion Criteria

Part A:
- Severe congenital diseases (e.g. infantile cerebral palsy, severe congenital malformations)
- Congenital or acquired immunodeficiencies
- COVID-19 infection in the child or parents already proven before the study
- Lack of consent for child or parent

Part B (Amendment 08.05.2020):
- Lack of consent for child/youth or adults
- Insufficient knowledge of German to understand the study information

Part C (Amendment 18.05.2021):
- Lack of consent for child/youth or adults
- Insufficient knowledge of German to understand the study information

Study & Design

• Study Type: observational
• Study Design: Not specified